Consolidated income statement
(x €1,000)
|
|
Notes |
2018 |
2017 Restated* |
|
|
|
|
|
|
Continuing operations |
|
|
|
|
Revenue |
5 |
7,207,751 |
6,535,092 |
|
|
|
||
|
Raw materials and consumables used |
|
(1,683,145) |
(1,322,539) |
|
Subcontracted work and other external charges |
|
(3,746,381) |
(3,630,419) |
|
Employee benefit expenses |
24 |
(1,338,319) |
(1,273,614) |
|
Depreciation and amortisation charges |
7,8 |
(69,776) |
(59,548) |
|
Impairment charges |
25 |
(20,628) |
(4,579) |
|
Other operating expenses |
|
(281,530) |
(254,142) |
|
Exchange rate differences |
|
1,417 |
29 |
|
|
|
(7,138,362) |
(6,544,812) |
|
|
|
|
|
|
Share of result of investments 1 |
10 |
38,947 |
20,317 |
|
Share of impairment charges in investments 1 |
10,25 |
(3,122) |
(193) |
|
|
|
35,825 |
20,124 |
|
Operating result |
|
105,214 |
10,404 |
|
|
|
|
|
|
Finance income |
28 |
21,221 |
30,002 |
|
Finance expense |
28 |
(11,894) |
(20,440) |
|
|
|
9,327 |
9,562 |
|
Result before tax |
|
114,541 |
19,966 |
|
|
|
|
|
|
Income tax |
29 |
(90,125) |
(32,891) |
|
Result for the year from continuing operations |
|
24,416 |
(12,925) |
|
Discontinued operations |
|
||
|
Result for the year from discontinued operations |
35 |
- |
- |
|
Net result |
|
24,416 |
(12,925) |
|
Attributable to: |
|
|
|
|
Shareholders of the Company |
|
23,773 |
(13,790) |
|
Non-controlling interests |
|
643 |
865 |
|
|
|
24,416 |
(12,925) |
|
Earnings per share (x €1) |
|
|
|
|
|
|
|
|
|
Basic |
30 |
|
|
|
Continuing operations |
|
0.09 |
(0.05) |
|
Discontinued operations |
|
- |
- |
|
Total |
|
0.09 |
(0.05) |
|
|
|
|
|
|
Diluted |
30 |
|
|
|
Continuing operations |
|
0.09 |
(0.05) |
|
Discontinued operations |
|
- |
- |
|
Total |
|
0.09 |
(0.05) |
* The comparative figures, where applicable, have been restated for IFRS 15. See note 2.
1 The results from share of investments (including impairments) have been included in the Operating result as from 2018. The comparative figures have been adjusted. Please see Note 2.1.1.
The notes on pages 107 to 189 are an integral part of these consolidated financial statements.